One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Table of contents
doi : 10.1016/S0190-9622(23)03382-0
Volume 90, Issue 3, March 2024, Pages A6, A9-A10, A14-A16, A26-A31
Information for readers
doi : 10.1016/S0190-9622(23)03383-2
Volume 90, Issue 3, March 2024, Page A32
JAAD Case Reports article list
doi : 10.1016/S0190-9622(23)03384-4
Volume 90, Issue 3, March 2024, Pages A43, A48
Journal based CME instructions and information
doi : 10.1016/S0190-9622(23)03385-6
Volume 90, Issue 3, March 2024, Page A50
Erythromelalgia. Part I: Pathogenesis, clinical features, evaluation, and complications
Elena Gonzalez Caldito, MD, a Subuhi Kaul, MD, a Natalia Gonzalez Caldito, MD, b Warren Piette, MD, a,c and Shilpa Mehta, MD
doi : 10.1016/j.jaad.2023.02.071
Volume 90, Issue 3, March 2024, Pages 453-462
Answers to CME examination
doi : 10.1016/j.jaad.2023.12.019
Volume 90, Issue 3, March 2024, Page 464
Erythromelalgia. Part II: Differential diagnoses and management
Elena Gonzalez Caldito, MD, a Natalia Gonzalez Caldito, MD, b Subuhi Kaul, MD, a Warren Piette, MD, a,c and Shilpa Mehta, MD
doi : 10.1016/j.jaad.2023.02.070
Volume 90, Issue 3, March 2024, Pages 465-474
Answers to CME examination
doi : 10.1016/j.jaad.2023.12.021
Volume 90, Issue 3, March 2024, Page 476
Letter from the Editor: Chemical exposure and sclerosing disorders
Dirk M. Elston, MD
doi : 10.1016/j.jaad.2023.05.026
Volume 90, Issue 3, March 2024, Pages 477-478
JAAD Game Changer: Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1Â year: Results from the CLEAR study
Robert Sorensen, MD
doi : 10.1016/j.jaad.2023.08.052
Volume 90, Issue 3, March 2024, Page 478
This month in JAAD: March 2024
Dirk M. Elston, MD
doi : 10.1016/j.jaad.2023.12.023
Volume 90, Issue 3, March 2024, Page 479
This Month in JAAD Case Reports: March 2024 postoperative bleeding risk when taking both warfarin and acetaminophen
Brett Sloan, MD
doi : 10.1016/j.jaad.2023.12.031
Volume 90, Issue 3, March 2024, Pages 480-481
JAAD Game Changer: Impact of scalp location on survival in head and neck melanoma: A retrospective cohort study
Robert Sorensen, MD
doi : 10.1016/j.jaad.2023.08.053
Volume 90, Issue 3, March 2024, Page 481
This month in JAAD International: March 2024: ChatGPT and large language models in the clinic
Jonathan Kantor, MD, MSc, MSCE
doi : 10.1016/j.jaad.2024.01.001
Volume 90, Issue 3, March 2024, Page 482
Atopic dermatitis: The perpetual need for science and art
Warren R. Heymann, MD
doi : 10.1016/j.jaad.2023.12.044
Volume 90, Issue 3, March 2024, Pages 483-484
JAAD Game Changer: The positive impact of radiologic imaging on high-stage cutaneous squamous cell carcinoma management
Robert Sorensen, MD
doi : 10.1016/j.jaad.2023.08.054
Volume 90, Issue 3, March 2024, Page 484
Efficacy and safety of apremilast in patients with moderate-to-severe genital psoriasis: Results from DISCREET, a phase 3 randomized, double-blind, placebo-controlled trial
Joseph F. Merola, MD, MMSc, a Lawrence Charles Parish, MD, MD (Hon), b Lyn Guenther, MD, c Charles Lynde, MD, d,e Jean-Philippe Lacour, MD, f Petra Staubach, MD, g Sue Cheng, MD, PhD, h Maria Paris, MD, i Hernan Picard, MD, PhD, h Cynthia Deignan, PhD, j Shauna Jardon, PharmD, j Mindy Chen, MS, h and Kim A. Papp, MD, PhD k
doi : 10.1016/j.jaad.2023.10.020
Volume 90, Issue 3, March 2024, Pages 485-493
JAAD Game Changer: Prevalence and risk of migraine in patients with rosacea: A population-based cohort study
Robert Sorensen, MD
doi : 10.1016/j.jaad.2023.08.055
Volume 90, Issue 3, March 2024, Page 493
Orismilast in moderate-to-severe psoriasis: Efficacy and safety from a 16-week, randomized, double-blinded, placebo-controlled, dose-finding, and phase 2b trial (IASOS)
Richard B. Warren, BSc, MBChB (Hons), PhD, a,b Lars E. French, MD, c,d Andrew Blauvelt, MD, MBA, e Richard G. Langley, MD, f Alexander Egeberg, MD, PhD, DMSc, g,h Ulrich Mrowietz, MD, i Hamish J. A. Hunter, BSc (Hons), PhD, MRCP, a,b,j Melinda Gooderham, MSc, MD, k,l Per Soerensen, MSc, m Philippe Andres, MD, m Morten O. A. Sommer, PhD, m,n Anna Carlsson, MSc, m Kim D. Kj?ller, MD, m and Bruce E. Strober, MD, PhD
doi : 10.1016/j.jaad.2023.11.005
Volume 90, Issue 3, March 2024, Pages 494-503
Safety and efficacy of eblasakimab, an interleukin 13 receptor α1 monoclonal antibody, in adults with moderate-to-severe atopic dermatitis: A phase 1b, multiple-ascending dose study
Karen A. Veverka, PhD, a Steven T. G. Thng, MD, b Jonathan I. Silverberg, MD, PhD, MPH, c April W. Armstrong, MD, MPH, d Josemund Menezes, MBBS, BCMAS, a Alexandre Kaoukhov, MD, a and Andrew Blauvelt, MD, MBA
doi : 10.1016/j.jaad.2023.10.026
Volume 90, Issue 3, March 2024, Pages 504-511
Impact of dupilumab on patch test results and allergic contact dermatitis: A prospective multicenter study
Sarah Bocquel, MD, a Angele Soria, MD-PHD, b Nadia Raison-Peyron, MD, c Antoine Badaoui, MD, d Pierre Marcant, MD, e Corina Bara, MD, f Franc¸oise Giordano-Labadie, MD, g Emmanuelle Amsler, MD, b Brigitte Milpied, MD, h Juliette Delaunay, MD, i Anne-Sophie Darrigade, MD, j Pauline Pralong, MD, k Claire Boulard, MD, l Marie-Christine Ferrier Le Bouedec, MD, m Marie Tauber, MD-PHD, g Justine Pasteur, MD, m Aude Valois, MD, n Aurelie Le Thuaut, MsC, o Marie-No€elle Crepy, MD, p and Claire Bernier, MD
doi : 10.1016/j.jaad.2023.10.029
Volume 90, Issue 3, March 2024, Pages 512-520
Efficacy and safety of the oral Janus kinase 1 inhibitor povorcitinib (INCB054707) in patients with hidradenitis suppurativa in a phase 2, randomized, double-blind, dose-ranging, placebo-controlled study
Joslyn S. Kirby, MD, MS, MEd, a Martin M. Okun, MD, PhD, b Afsaneh Alavi, MD, c Falk G. Bechara, MD, d Christos C. Zouboulis, MD, PhD, e Kurt Brown, MD, f Leandro L. Santos, MS, f Annie Wang, PhD, f Kristen B. Bibeau, PhD, MSPH, f Alexa B. Kimball, MD, g and Martina L. Porter, MD
doi : 10.1016/j.jaad.2023.10.034
Volume 90, Issue 3, March 2024, Pages 521-529
JAAD Game Changer: Quality of life in adults with facial port-wine stains
Robert Sorensen, MD
doi : 10.1016/j.jaad.2023.08.056
Volume 90, Issue 3, March 2024, Page 529
Cumulative incidence and timing of subsequent cutaneous squamous cell carcinomas stratified for patients with organ transplantation and hematologic malignancies: A nationwide cohort study
Celeste J. Eggermont, MD, a Loes M. Hollestein, PhD, a,b Andrya Hollatz, BSc, a Marieke Louwman, PhD, b Antien L. Mooyaart, MD, PhD, c Tamar Nijsten, MD, PhD, a and Marlies Wakkee, MD, PhD a
doi : 10.1016/j.jaad.2023.10.036
Volume 90, Issue 3, March 2024, Pages 530-536
International expert recommendations on image acquisition for in vivo reflectance confocal microscopy of cutaneous tumors
Genevieve Ho, MD, a,b,c Melissa Gill, MD, d,e Jane Grant-Kels, MD, f,g Rodrigo J. Schwartz, MD, a,h Giovanni Pellacani, MD, i Salvador Gonzalez, MD, PhD, j Christi Alessi-Fox, MS, k and Pascale Guitera, MD
doi : 10.1016/j.jaad.2023.09.086
Volume 90, Issue 3, March 2024, Pages 537-544
JAAD Game Changer: A clinical, histologic, and follow-up study of genital melanosis in men and women
Robert Sorensen, MD
doi : 10.1016/j.jaad.2023.08.066
Volume 90, Issue 3, March 2024, Page 544
A multicenter real-world analysis of risk factors, therapeutics, and outcomes of patients with metastatic basal cell carcinoma
Morgan Groover, BS, a Neha Gupta, MD, MPH, a Emily Granger, BS, a Vernon J. Forrester, MD, b Emily J. Anstadt, MD, PhD, c William Su, MD, c Lauren Heusinkveld, MD, b Anna Chen, BS, a John N. Lukens, MD, c Ann W. Silk, MD, MS, d Allison T. Vidimos, RPh, MD, b Jonathan D. Schoenfeld, MD, MPH, e Shlomo A. Koyfman, MD, f and Emily S. Ruiz, MD, MPH
doi : 10.1016/j.jaad.2023.10.060
Volume 90, Issue 3, March 2024, Pages 545-551
The epidemiology of acne vulgaris in a multiethnic adolescent population from Rotterdam, the Netherlands: A cross-sectional study
Willemijn C. A. M. Witkam, MD, a,b Susi E. Dal Belo, PhD, c Sayeh Pourhamidi, MSc, c Edouard Raynaud, MD, c Magali Moreau, PhD, c Luc Aguilar, PhD, c Pauline W. Jansen, PhD, a,d,e Tamar E. C. Nijsten, MD, PhD, b and Luba M. Pardo, MD, PhD
doi : 10.1016/j.jaad.2023.10.062
Volume 90, Issue 3, March 2024, Pages 552-560
JAAD Game Changer: Assessment of major comorbidities in adults with atopic dermatitis using the Charlson comorbidity index
Robert Sorensen, MD
doi : 10.1016/j.jaad.2023.08.067
Volume 90, Issue 3, March 2024, Page 560
Risk of atopic dermatitis and the atopic march paradigm in children of mothers with atopic illnesses: A birth cohort study from the United Kingdom
Zelma C. Chiesa Fuxench, MD, MSCE, a Nandita Mitra, PhD, b Domenica Del Pozo, BA, c Ole Hoffstad, MS, a Daniel B. Shin, PhD, a and David J. Margolis, MD, PhD
doi : 10.1016/j.jaad.2023.11.013
Volume 90, Issue 3, March 2024, Pages 561-568
Merkel cell carcinoma recurrence risk estimation is improved by integrating factors beyond cancer stage: A multivariable model and web-based calculator
Aubriana M. McEvoy, MD, MS, a,b Daniel S. Hippe, MS, c Kristina Lachance, MS, a Song Park, MD, a Kelsey Cahill, BS, a Mary Redman, PhD, c Ted Gooley, PhD, c Michael W. Kattan, MBA, PhD, d and Paul Nghiem, MD, PhD
doi : 10.1016/j.jaad.2023.11.020
Volume 90, Issue 3, March 2024, Pages 569-576
Aesthetic outcome of intermediate closure versus intermediate closure followed by 2-octyl cyanoacrylate: A randomized evaluator-blinded split-wound comparative effectiveness trial
Zachary Kwapnoski, MD, Mohammad Saffari Doost, BA, Michelle Vy, MD, and Daniel B. Eisen, MD
doi : 10.1016/j.jaad.2023.10.028
Volume 90, Issue 3, March 2024, Pages 577-584
JAAD Game Changer: Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics
Faramarz H. Samie, MD, PhD
doi : 10.1016/j.jaad.2023.08.068
Volume 90, Issue 3, March 2024, Page 584
Nail psoriasis and nail lichen planus: Updates on diagnosis and management
Jonathan K. Hwang, BS, a Chander Grover, MD, b Matilde Iorizzo, MD, PhD, c Mark G. Lebwohl, MD, d Bianca M. Piraccini, MD, PhD, e,f Dimitris G. Rigopoulos, MD, g and Shari R. Lipner, MD, PhD
doi : 10.1016/j.jaad.2023.11.024
Volume 90, Issue 3, March 2024, Pages 585-596
JAAD Game Changer: Vitiligo and overt thyroid diseases: A nationwide population-based study in Korea
Robert Sorensen, MD
doi : 10.1016/j.jaad.2023.08.069
Volume 90, Issue 3, March 2024, Page 596
Unmet needs for patients with seborrheic dermatitis
J. Mark Jackson, MD, a Andrew Alexis, MD, MPH, b Matthew Zirwas, MD, c and Susan Taylor, MD
doi : 10.1016/j.jaad.2022.12.017
Volume 90, Issue 3, March 2024, Pages 597-604
Organic solvent exposure and systemic sclerosis: A retrospective cohort study based on the Canadian Scleroderma Research Group registry
Anastasiya Muntyanu, MD, a Raymond Milan, PhD, b Elham Rahme, PhD, b,c Murray Baron, MD, d Elena Netchiporouk, MD, MSc, e and the Canadian Scleroderma Research Group
doi : 10.1016/j.jaad.2023.04.062
Volume 90, Issue 3, March 2024, Pages 605-607
Association between alopecia areata and atopic dermatitis: A nested case-control study of the All of Us database
Michael J. Diaz, BS, a Zaim Haq, BS, b Parsa Abdi, BS, c Jasmine T. Tran, BS, d Emma Guttman- Yassky, MD, PhD, e and Benjamin Ungar, MD
doi : 10.1016/j.jaad.2023.10.031
Volume 90, Issue 3, March 2024, Pages 607-609
Factors associated with time to surgical treatment for dermatofibrosarcoma protuberans
Caroline M. Wilkowski, BS, a Jessica B. Brown- Korsah, MD, b Raghav Tripathi, MD, MPH, c and Jeremy S. Bordeaux, MD, MPH a,d,e
doi : 10.1016/j.jaad.2023.10.035
Volume 90, Issue 3, March 2024, Pages 609-612
The role of oral nutraceuticals as adjunctive therapy to reduce side effects from isotretinoin: A systematic review
Ali Shields, BS, a,b Sophia Ly, BA, b,c Bruna Wafae, MD,b,d Yu-Feng Chang, MD, MS, b,d Priya Manjaly, BA b,e Marjorie Archila, MS, b Christina Heinrich, MS, f Lara Drake, BA, b,f Arash Mostaghimi, MD, MPH, MPA, b,d and John S. Barbieri, MD, MBA
doi : 10.1016/j.jaad.2023.10.037
Volume 90, Issue 3, March 2024, Pages 612-615
Analysis of ChatGPT generated differential diagnoses in response to physical exam findings for benign and malignant cutaneous neoplasms
Chandler W. Rundle, MD, a Mindy D. Szeto, MS, b Colby L. Presley, DO, c Kathryn T. Shahwan, MD, d,e,f and David R. Carr, MD, MPH
doi : 10.1016/j.jaad.2023.10.040
Volume 90, Issue 3, March 2024, Pages 615-616
The burden of head-and-neck dermatitis in adults with atopic dermatitis and its association with asthma, rhinitis, and disease severity
Amalie Thorsti M?ller R?nnstad, MD, a Simon F. Thomsen, MD, PhD, DMSc, a,b Jacob P. Thyssen, MD, PhD, DMSc, a,c and Alexander Egeberg, MD, PhD, DMSc
doi : 10.1016/j.jaad.2023.10.042
Volume 90, Issue 3, March 2024, Pages 616-618
Increased diagnostic interval for nodular melanomas does not associate with increased tumor thickness or staging: Results from a single-center retrospective chart review
Sairekha Ravichandran, MD, a,b Isaac Briskin, MA, c and Joshua Arbesman, MD
doi : 10.1016/j.jaad.2023.09.087
Volume 90, Issue 3, March 2024, Pages 618-620
Real-world effectiveness of immune checkpoint inhibitors and BRAF/MEK inhibitors among veteran patients with cutaneous melanoma
Daniel Y. Kim, BS, a,b Susan M. Swetter, MD, c,d Linden Huhmann, MS, PhD, e Matthew P. Dizon, MD, d,f Jacqueline M. Ferguson, PhD, f Thomas F. Osborne, MD, g,h Allyson C. Spence, MD, PhD, i Amina Ziad, BS, a,b Nathanael Fillmore, PhD, a,e,j,k and Rebecca I. Hartman, MD, MPH
doi : 10.1016/j.jaad.2023.10.051
Volume 90, Issue 3, March 2024, Pages 620-623
Advanced melanoma presentation and disease-specific survival disparities among disaggregated Asian American, Native Hawaiian, and Pacific Islander populations
Daniel Y. Kim, BS, a Edward C. Dee, MD, b Iona Cheng, PhD, MPH, c,d and Rebecca I. Hartman, MD, MPH
doi : 10.1016/j.jaad.2023.10.052
Volume 90, Issue 3, March 2024, Pages 623-626
Epidemiology of patients admitted to dermatology service at a Southeastern US university hospital: A retrospective study
Taha F. Rasul, BS, Robert S. Kirsner, MD, PhD, and Scott A. Elman, MD
doi : 10.1016/j.jaad.2023.10.053
Volume 90, Issue 3, March 2024, Pages 626-627
Increased Janus kinase activation in cutaneous vasculitis
Aoi Ebata, MD, Mariko Ogawa-Momohara, MD, PhD, Ryo Fukaura, MBBS, Yuta Yamashita, MD, PhD, Haruka Koizumi, MD, Takuya Takeichi, MD, PhD, Yoshinao Muro, MD, PhD, and Masashi Akiyama, MD, PhD
doi : 10.1016/j.jaad.2023.10.056
Volume 90, Issue 3, March 2024, Pages 627-629
Biomarkers of response to topical crisaborole in patients with mild/moderate pediatric atopic dermatitis from minimally invasive tape strip transcriptome
Anna B. Fishbein, MD, MS, a Janak Mukherji, a Michael Demczuk, b Brooke Buranosky, a Jack Osborn, a Crista Moreno, c Dominic LaRoche, MS, c Amy S. Paller, MS, MD, b and Kurt Q. Lu, MD
doi : 10.1016/j.jaad.2023.10.057
Volume 90, Issue 3, March 2024, Pages 629-632
Dermatology representation in academic clinical gender care programs in the United States: A cross-sectional study
Soumya A. Reddy, BSA, a Caroline Fisher, BS, b Matthew D. Mansh, MD, c and J. Klint Peebles, MD
doi : 10.1016/j.jaad.2023.10.058
Volume 90, Issue 3, March 2024, Pages 632-635
Preliminary summary and reclassification of cases from the Pediatric Research of Management in Stevens-Johnson syndrome and Epidermonecrolysis (PROMISE) study: A North American, multisite retrospective cohort
Sylvia Martinez-Cabriales, MD, a Jerome Coulombe, MD, b Michelle Aaron, MD, c Sadaf H. Hussain, MD, d Danny Linggonegoro, MD, d Irene Lara- Corrales, MD, e Hailey Barootes, MD, e Heather Brandling-Bennett, MD, f Isabela Covelli, MD, f Anna Yasmine Kirkorian, MD, g Nidhi Shah, MD, g Leslie Castelo-Soccio, MD, h Paige McKenzie, MD, h Lisa M. Arkin, MD, i Adam Heinze, MD, i Carmen Liy-Wong, MD, j Nicole Travis, MD, j Michael Rieder, MD, k Blanca R. Del Pozzo-Magana, MD, k Jennifer J. Schoch, MD, l Reesa Monir, MD, l Sharon A. Glick, MD
doi : 10.1016/j.jaad.2023.08.112
Volume 90, Issue 3, March 2024, Pages 635-637
Melanoma incidence and mortality: Exploring the impact of regional ultraviolet (UV) radiation and socioeconomic status in the context of Breslow thickness
Jalal Maghfour, MD, a Pin Li, PhD, b Austin Piontkowski, BS, c David Ozog, MD, a,d Qing- Sheng Mi, MD, PhD, a,d and Jesse Veenstra, MD, PhD
doi : 10.1016/j.jaad.2023.11.003
Volume 90, Issue 3, March 2024, Pages 637-640
Trends in US dermatology physician assistant density 2016 to 2023: A cross-sectional analysis
Joshua Burshtein, MD, a,b Danny Zakria, MD, MBA, a,b Milaan Shah, MD, a,b Lauren Miller, PA-C, c and Darrell Rigel, MD, MS
doi : 10.1016/j.jaad.2023.11.009
Volume 90, Issue 3, March 2024, Pages 640-642
Methotrexate for pyoderma gangrenosum: A retrospective case series of 33 patients
Josiah A. Williams, MD, a Matthew L. Hrin, MD, a Nathan L. Bowers, MD, PhD, a Joseph L. Jorizzo, MD, a Steven R. Feldman, MD, PhD, a,b,c,d and William W. Huang, MD, MPH
doi : 10.1016/j.jaad.2023.10.063
Volume 90, Issue 3, March 2024, Pages 642-644
Association between out-of-pocket expense and patient satisfaction with cutaneous surgery: A prospective, randomized study
Michael D. Yi, BS, a Umer Nadir, BS, a Farhana Ikmal Hisham, MA, a Loma Dave, BS, a Amanda Maisel-Campbell, MD, a Alexandra Weil, BS, a Emily Poon, PhD, a Brian A. Cahn, MD, b Ross Pearlman, MD, a and Murad Alam, MD, MSCI, MBA
doi : 10.1016/j.jaad.2023.11.011
Volume 90, Issue 3, March 2024, Pages 644-646
Systemic therapy in treating palmoplantar and scalp psoriasis: A systematic review and network meta-analysis
Lu Zhang, MD, a,b Yaoxi Su, MD, a,b Huidi Shucheng, MD, a,b Lian Wang, MD, a,b and Xian Jiang, MD
doi : 10.1016/j.jaad.2023.10.064
Volume 90, Issue 3, March 2024, Pages 646-648
Cutaneous immune-related adverse event burden and effect on immunotherapy: A retrospective review of the experience at a tertiary care immunotherapy center
Thomas K. Le, MD, MPH, a,b Elizabeth Schoenberg Newland, MD, a Isabelle Brown, BS, a Rebecca Goldberg, MD, c Yevgeniy R. Semenov, MD, MA, d and Shawn G. Kwatra, MD
doi : 10.1016/j.jaad.2023.10.065
Volume 90, Issue 3, March 2024, Pages 648-650
Lichen planus is associated with other autoimmune conditions: A retrospective population-level study
Alexa Kassels, BS, a Ashley N. Elsensohn, MD, MPH, b and Christina N. Kraus, MD
doi : 10.1016/j.jaad.2023.11.016
Volume 90, Issue 3, March 2024, Pages 650-652
Methotrexate and acitretin in pityriasis rubra pilaris: A retrospective cohort study
Jonathan D. Greenzaid, BS, a Matthew L. Hrin, MD, a Steven R. Feldman, MD, PhD, a,b,c,d and Lindsay C. Strowd, MD
doi : 10.1016/j.jaad.2023.11.017
Volume 90, Issue 3, March 2024, Pages 652-654
COVID-19 pandemic-related decreases in hand, foot, and mouth disease and scabies: A retrospective study
Ania Stolarczyk, BS, Julie Ryan Wolf, PhD, MPH, and Alice Pentland, MD
doi : 10.1016/j.jaad.2023.11.018
Volume 90, Issue 3, March 2024, Pages 654-655
Prevalence of advanced practice providers identified as physicians in online patient reviews: A cross-sectional study
Jessica Johnson, BS, a Judy Zhang, BS, BA, a Rashmi Unwala, MD, b and Christine B. Warren, MD, MS
doi : 10.1016/j.jaad.2023.11.019
Volume 90, Issue 3, March 2024, Pages 656-657
Delusions of parasitosis: A retrospective case control study examining biometric and pharmaceutical associations
Anissa Bernardez, MD, a Debolina Kanjilal, MD, b An-Lin Cheng, PhD, c and Colleen Reisz, MD
doi : 10.1016/j.jaad.2023.11.023
Volume 90, Issue 3, March 2024, Pages 657-659
Comparison of comorbidities and adverse events in dermatology and rheumatology patients prescribed tofacitinib: A retrospective analysis
Carli D. Needle, BA, a Elizabeth J. Klein, MD, a Jessica Gjonaj, BA, b Ambika Nohria, BA, a Maria Karim, MD, c Lynn Liu, MD, a Jinal Shah, MPH, b Rebecca A. Betensky, PhD, b Michael Garshick, MD, a,d Kristen Lo Sicco, MD, a and Theodora K. Karagounis, MD
doi : 10.1016/j.jaad.2023.11.027
Volume 90, Issue 3, March 2024, Pages 659-662
Risk of infections among patients with psoriasis on Janus kinase inhibitor treatment: A systematic review and meta-analysis
Nawar Tarafdar, BSc, a Muskaan Sachdeva, MD, b Natnaiel M. Dubale, BSc, a Iryna Savinova, BSc, c Yuliya Lytvyn, MD, PhD, b Khalad Maliyar, MD, b Jorge R. Georgakopoulos, MD, b Asfandyar Mufti, MD, FRCPC, b,d and Jensen Yeung, MD, FRCPC
doi : 10.1016/j.jaad.2023.10.066
Volume 90, Issue 3, March 2024, Pages 662-665
Squamous cell carcinoma incidence, demographics, and outcomes in skin of color patients
Deborah Paul, MD, Austin Todd, MS, and Christian Baum, MD
doi : 10.1016/j.jaad.2023.11.029
Volume 90, Issue 3, March 2024, Pages 665-666
Obstructive sleep apnea among patients with psoriasis: A case-control study in the All of Us Research Program
Vikram R. Shaw, MS, a Lauren A. Tobias, MD, b,c and Jeffrey M. Cohen, MD
doi : 10.1016/j.jaad.2023.11.031
Volume 90, Issue 3, March 2024, Pages 666-668
ChatRx: ChatGPT’s potential to educate patients on medication adverse effects
Annie I. Chen, BS, a Laura K. Ferris, MD, PhD, a Vinod E. Nambudiri, MD, MBA, EdM, b,c and Evan W. Piette, MD
doi : 10.1016/j.jaad.2023.11.008
Volume 90, Issue 3, March 2024, Pages 669-670
JAAD Game Changer: A predictive model for diagnosis of lower extremity cellulitis: A cross-sectional study
Robert Sorensen, MD
doi : 10.1016/j.jaad.2023.08.070
Volume 90, Issue 3, March 2024, Page 670
What to do when you are curbsided by your patient’s plus one
Ayush Sangari, MS, a Aditya Sood, BS, b and Benjamin K. Stoff, MD, MA
doi : 10.1016/j.jaad.2022.08.032
Volume 90, Issue 3, March 2024, Pages 671-672
JAAD Game Changer: Alcohol intake and risk of rosacea in US women
Robert Sorensen, MD
doi : 10.1016/j.jaad.2023.08.071
Volume 90, Issue 3, March 2024, Page 672
The doctor will see (all of) you now: Ethical dilemmas in double-booking patients
Eric J. Beltrami, BS, a and Jane M. Grant-Kels, MD
doi : 10.1016/j.jaad.2022.11.046
Volume 90, Issue 3, March 2024, Pages 673-674
JAAD Game Changer: Clinical and dermoscopic features of cutaneous BAP1-inactivated melanocytic tumors: Results of a multicenter case-control study by the International Dermoscopy Society
Jane Margaret Grant-Kels, MD
doi : 10.1016/j.jaad.2023.09.003
Volume 90, Issue 3, March 2024, Page 674
Ethics of conflicts of interest in medical authorship
Sonal Muzumdar, MD, a and Jane M. Grant-Kels, MD
doi : 10.1016/j.jaad.2022.12.032
Volume 90, Issue 3, March 2024, Pages 675-676
JAAD Game Changer: Medical and aesthetic procedural dermatology recommendations for transgender patients undergoing transition
Jane Margaret Grant-Kels, MD
doi : 10.1016/j.jaad.2023.09.004
Volume 90, Issue 3, March 2024, Page 676
Sterile polyethylene film: A novel application for the treatment of facial pediatric scald burns
Chao Lian, MD, a,b Xuan-Fen Zhang, MD, a Xue-Lei Li, MD, b and Xiao-Jun Liu, MD
doi : 10.1016/j.jaad.2022.10.057
Volume 90, Issue 3, March 2024, Pages e87-e88
A simple video demonstrating the deroofing technique for hidradenitis suppurativa
Meredith Hengy, BS, a and Steven Daveluy, MD
doi : 10.1016/j.jaad.2022.11.011
Volume 90, Issue 3, March 2024, Page e89
Use of a permanent magnet to control surgical sharps
Le Zhuang, MD, Fu Qiang Chen, BA, and Qing Sun, MD
doi : 10.1016/j.jaad.2022.09.059
Volume 90, Issue 3, March 2024, Pages e91-e92
Subcision modification to prevent intraoperative blood spillage and to keep the needle aligned
Bhavya Swarnkar, MD, Avik Mondal, MBBS, and Somesh Gupta, MD
doi : 10.1016/j.jaad.2022.12.010
Volume 90, Issue 3, March 2024, Pages e93-e94
Modified linear closure with standing cone management: An alternative to the purse string suture
Hannah Y. Wang, BS, a Suzanne Alkul, MD, b Ikue Shimizu, MD, b and Jennifer Ranario, MD, MBA
doi : 10.1016/j.jaad.2022.12.030
Volume 90, Issue 3, March 2024, Pages e95-e96
Basic mold to improve tissue processing efficiency and consistency in Mohs surgery
Ryan Ladd, MD, Debra Keith, HT (ASCP), and Shari Ochoa, MD
doi : 10.1016/j.jaad.2023.03.017
Volume 90, Issue 3, March 2024, Pages e97-e98
A modified needle knife using electrosurgical electrode in skin surgery
Qiuyun Xu, MD, a Zugen Huang, MD, b Shuyi Shen, MD, a Manlin Yan, MD, c Ting Gong, PhD, d and Chao Ji, PhD
doi : 10.1016/j.jaad.2023.02.060
Volume 90, Issue 3, March 2024, Pages e99-e100
Considerations for perioperative antibiotic prophylaxis in Mohs micrographic surgery
Tejas P. Joshi, BS, a Usman Asad, MD, b and Zeena Y. Nawas, MD
doi : 10.1016/j.jaad.2023.09.085
Volume 90, Issue 3, March 2024, Page e101
Response to Joshi et al’s “Considerations for perioperative antibiotic prophylaxis in Mohs micrographic surgery�
Kyle C. Lauck, MD, a Hamza Malick, BS, b and Stanislav N. Tolkachjov, MD
doi : 10.1016/j.jaad.2023.10.019
Volume 90, Issue 3, March 2024, Pages e103-e104
Response to Jin and Dobry's “ChatGPT for health care providers and patients: Practical implications within dermatology�
Melinda Jiang, MD,a,b Stephen Bacchi, PhD, c,d,e Joshua Kovoor, MBBS, a,e Brandon Stretton, MBBS, f,g and Weng Onn Chan, Mphil
doi : 10.1016/j.jaad.2023.10.038
Volume 90, Issue 3, March 2024, Page e105
Guidance on screening magnetic resonance imaging decisions for congenital melanocytic nevi
Holly Neale, MD, a,b Isabella Plumptre, MBBS, a Leah Belazarian, MD, a,c Karen Wiss, MD, a,c and Elena B. Hawryluk, MD, PhD b,
doi : 10.1016/j.jaad.2023.10.061
Volume 90, Issue 3, March 2024, Pages e107-e108
Response to “Guidance on screening MRI decisions for congenital melanocytic nevi�
Veronica A. Kinsler, MB, BChir, MA, PhD
doi : 10.1016/j.jaad.2023.07.1050
Volume 90, Issue 3, March 2024, Pages e109-e110
March 2024 IOTADERMA (#361)
Robert I. Rudolph, MD, FACP
doi : 10.1016/j.jaad.2023.09.011
Volume 90, Issue 3, March 2024, Page e111
